Search

Author/Creator Blauvelt, Andrew

31. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Issue 10086 (10th June 2017)

Authors:
Blauvelt, Andrew; de Bruin-Weller, Marjolein; Gooderham, Melinda; Cather, Jennifer C; Weisman, Jamie; Pariser, David; Simpson, Eric L; Papp, Kim A; Hong, H Chih-Ho; Rubel, Diana; Foley, Peter; Prens, Errol; Griffiths, Christopher E M; Etoh, Takafumi; Pinto, Pedro Herranz; Pujol, Ramon M; Szepieto...
Journal:
Lancet
Issue:
Volume 389:Issue 10086(2017)
Page Start:
2287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

32. Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials. Issue 1 (31st May 2019)

Authors:
Curtis, Jeffrey R; Mariette, Xavier; Gaujoux-Viala, Cécile; Blauvelt, Andrew; Kvien, Tore K; Sandborn, William J; Winthrop, Kevin; de Longueville, Marc; Huybrechts, Ivo; Bykerk, Vivian P
Journal:
RMD open
Issue:
Volume 5:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

33. Long‐term Efficacy, Safety, and Immunogenicity Data From a Phase III Confirmatory Study Comparing GP2017, a Proposed Biosimilar, With Reference Adalimumab: 751. (October 2017)

Authors:
Blauvelt, Andrew; Lacour, Jean‐Phillippe; Fowler, Joseph F.; Schuck, Ellen; Jauch‐Lembach, Julia; Balfour, Alison; Leonardi, Craig L.
Journal:
American journal of gastroenterology
Issue:
Volume 112(2017)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

34. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials. Issue 10290 (5th June 2021)

Authors:
Guttman-Yassky, Emma; Teixeira, Henrique D; Simpson, Eric L; Papp, Kim A; Pangan, Aileen L; Blauvelt, Andrew; Thaçi, Diamant; Chu, Chia-Yu; Hong, H Chih-ho; Katoh, Norito; Paller, Amy S; Calimlim, Brian; Gu, Yihua; Hu, Xiaofei; Liu, Meng; Yang, Yang; Liu, John; Tenorio, Allan R; Chu, Alvina D; Ir...
Journal:
Lancet
Issue:
Volume 397:Issue 10290(2021)
Page Start:
2151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study. Issue 1 (January 2023)

Authors:
Blauvelt, Andrew; Pariser, David M.; Tyring, Stephen; Bagel, Jerry; Alexis, Andrew F.; Soung, Jennifer; Armstrong, April W.; Muscianisi, Elisa; Kianifard, Farid; Steadman, Jennifer; Sarkar, Rajendra Prasad; Garcet, Sandra; Krueger, James G.
Journal:
Journal of dermatological science
Issue:
Volume 109:Issue 1(2023)
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

36. Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis. (21st September 2022)

Authors:
Blauvelt, Andrew; Kircik, Leon; Papp, Kim A.; Simpson, Eric L.; Silverberg, Jonathan I.; Kim, Brian S.; Kwatra, Shawn G.; Kuligowski, Michael E.; Venturanza, May E.; Wei, Shaoceng; Szepietowski, Jacek C.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 37:Number 1(2023)
Page Start:
137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

39. SAT0605 BODY MASS INDEX AND SYSTEMIC CORTICOSTEROID USE AS INDICATORS OF DISEASE BURDEN AND THEIR INFLUENCE ON THE SAFETY PROFILE OF CERTOLIZUMAB PEGOL ACROSS INDICATIONS. (June 2019)

Authors:
Bykerk, Vivian; Blauvelt, Andrew; Curtis, Jeffrey; Gaujoux-Viala, Cecile; Kvien, Tore K.; Sandborn, William; Winthrop, Kevin; Popova, Christina; Mariette, Xavier
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
1396
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

40. Secukinumab, a novel anti-IL-17A antibody, exhibits low immunogenicity in clinical trials and human in vitro assays. Issue 1 (October 2016)

Authors:
Kolbinger, Frank; Blauvelt, Andrew; Armstrong, April; Fox, Todd; Huang, Jiaqing; Liang, Eric; Karle, Annette; Spindeldreher, Sebastian; Bruin, Gerard; Reich, Kristian
Journal:
Journal of dermatological science
Issue:
Volume 84:Issue 1(2016:Oct.)
Page Start:
e122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗